Completed PHASE2 INTERVENTIONAL 2-arm NCT03289403

The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis

The Role of Immunomodulatory Treatment in Success of ICSI in Patients Who Have Infertility With Autoimmune Thyroiditis

Sponsor: Aljazeera Hospital

Conditions Autoimmune Thyroiditis Infertility

Interventions Immunomodulatory Thyroxine

Updated 8 times since 2017 Last updated: Dec 23, 2024 Started: Mar 7, 2018 Primary completion: Sep 15, 2023 Completion: Jan 20, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03289403, this PHASE2 trial focuses on Autoimmune Thyroiditis and Infertility and remains completed. Sponsored by Aljazeera Hospital, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Jan 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Jan 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jul 2020 — Jan 2021 [monthly]

Completed PHASE2

Status: Recruiting → Completed

▶ Show 3 earlier versions

Feb 2019 — Jul 2020 [monthly]

Recruiting PHASE2
Jun 2018 — Feb 2019 [monthly]

Recruiting PHASE2
Oct 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aljazeera Hospital

Data source: Aljazeera Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Giza, Egypt